Copyright
©The Author(s) 2017.
World J Diabetes. Jul 15, 2017; 8(7): 317-329
Published online Jul 15, 2017. doi: 10.4239/wjd.v8.i7.317
Published online Jul 15, 2017. doi: 10.4239/wjd.v8.i7.317
Figure 2 Schematic presentation of the multiple pathways involved in metabolic syndrome including hypertension, central obesity, dyslipidemia, adipose tissue and adipokine’s dysfunction, altered free fatty acids levels and polyunsaturated fatty acid metabolism leading to local and systemic inflammation.
FFA: Free fatty acids; PUFA: Polyunsaturated fatty acid.
- Citation: Mbata O, Abo El-Magd NF, El-Remessy AB. Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia. World J Diabetes 2017; 8(7): 317-329
- URL: https://www.wjgnet.com/1948-9358/full/v8/i7/317.htm
- DOI: https://dx.doi.org/10.4239/wjd.v8.i7.317